meglumine has been researched along with Kahler Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beaussart, P; Belhadj, K; Cuenod, CA; Deux, JF; Haioun, C; Kuhnowski, F; Lin, C; Luciani, A; Maatouk, M; Rahmouni, A | 1 |
| Bartl, R; Baur, A; Lamerz, R; Reiser, M; Stäbler, A | 1 |
2 other study(ies) available for meglumine and Kahler Disease
| Article | Year |
|---|---|
Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging.
Topics: Adult; Aged; Bone Marrow; Contrast Media; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Myeloma; Organometallic Compounds; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Whole Body Imaging | 2010 |
[Infiltration patterns of plasmacytomas in magnetic resonance tomography].
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Bone Marrow; Bone Marrow Examination; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multiple Myeloma; Organometallic Compounds; Pentetic Acid; Radiography; Spine | 1996 |